Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04882202
Other study ID # 3-2021-0087
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2021
Est. completion date December 30, 2024

Study information

Verified date February 2024
Source Gangnam Severance Hospital
Contact SungYeon Ham
Phone 82-2-2019-4601
Email SYID0424@yuhs.ac
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Acute kidney injury is commonly accompanied major complication after aortic surgery. Cardipulmonary bypass lyses erythrocyte and induces lipid peroxidation. This increases plasma free hemoglobin, F2-isoprostane, and isofuran concentration. Cell free hemoglobin have been reported to be associated with poor prognosis such as acute kidney injury, myocardial infarction, and death. Acetaminophen is reported to attenuate hemeprotein mediated lipid peroxidation. Thus, investigators hypothesized that acetaminophen might have protective effect on the incidence of acute kidney injury in patients undergoing aortic surgery with moderate hypothermic circulatory arrest.


Recruitment information / eligibility

Status Recruiting
Enrollment 136
Est. completion date December 30, 2024
Est. primary completion date December 30, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 100 Years
Eligibility Inclusion Criteria: 1) Patients undergoing aortic surgery with moderate hypothermic circulatory arrest. Exclusion Criteria: 1. patients with chronic kidney disease or with dialysis, eGFR < 15ml/min/1.73m2 2. allergy to acetaminophen or propacetamol HCl 3. history of liver cirrhosis or total bilirubin > 2.0mg/dL 3) patients taking acetaminophen or diclofenac 4) patients who cannot understand informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Acetaminophen
Acetaminophen 1g IV every 6 hours for a weight > 50kg (maximum of 4g per 24 hours) or 15mg/kg every 6 hours for a weight < 50kg (maximum of 75mg/kg per 24 hours)
Other:
Placebo
Normal saline 100 ml (equal amount of acetaminophen) IV every 6 hours

Locations

Country Name City State
Korea, Republic of Gangnam Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Gangnam Severance Hospital

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Simpson SA, Zaccagni H, Bichell DP, Christian KG, Mettler BA, Donahue BS, Roberts LJ 2nd, Pretorius M. Acetaminophen attenuates lipid peroxidation in children undergoing cardiopulmonary bypass. Pediatr Crit Care Med. 2014 Jul;15(6):503-10. doi: 10.1097/PCC.0000000000000149. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of acute kidney injury after aortic surgery with moderate hypothermic circulatory arrest Compare the incidence of acute kidney injury within 7 days after surgery. Acute kidney injury is defined using KDIGO criteria. Postoperative 7 days
See also
  Status Clinical Trial Phase
Completed NCT03817008 - Changes in Elastic Properties of Descending Thoracic Aorta After Ascending Aorta Replacement
Recruiting NCT03009643 - Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery N/A
Completed NCT05171023 - Application of ROTEM Technology in Aortic Surgery
Completed NCT02157337 - The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery Phase 4
Completed NCT03469765 - (TIMP-2)x(IGFPB7) to Predict Acute Kidney Injury (AKI) in Aortic Surgery
Recruiting NCT04350697 - Mini-invasive Approaches to Aortic Surgery
Completed NCT05049590 - Acute Normovolemic Hemodilution in Complex Cardiac Surgery Phase 3
Completed NCT01844219 - Accuracy of Pre-existing Risk Scoring Models for Predicting Acute Kidney Injury in Patients Who Underwent Aortic Surgery Using a Gray Zone Approach N/A